Stay updated on Arbaclofen in Children and Adolescents With ASD Clinical Trial
Sign up to get notified when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.

Latest updates to the Arbaclofen in Children and Adolescents With ASD Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a publication entry for the AIMS-2-TRIALS-CT1 study (EClinicalMedicine, 2026) under Publications, and included revision note v3.4.2.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with references to cc.nih.gov and opm.gov. Revision metadata updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary toggle added and glossary UI is now visible. QC metadata labels and revision info were updated (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0).SummaryDifference0.2%

- Check42 days agoChange DetectedThe page shows a minor revision label updated from v3.3.3 to v3.3.4; no study content or critical navigation elements were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter now shows Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to Arbaclofen in Children and Adolescents With ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arbaclofen in Children and Adolescents With ASD Clinical Trial page.